Free Trial
NASDAQ:PRTG

Portage Biotech (PRTG) Stock Price, News & Analysis

Portage Biotech logo
$7.02 +1.15 (+19.59%)
Closing price 08/5/2025 03:59 PM Eastern
Extended Trading
$7.12 +0.10 (+1.35%)
As of 08/5/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Portage Biotech Stock (NASDAQ:PRTG)

Key Stats

Today's Range
$5.89
$7.25
50-Day Range
$5.29
$8.68
52-Week Range
$2.10
$23.01
Volume
153,563 shs
Average Volume
19,741 shs
Market Capitalization
$7.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter.

PRTG Stock News Headlines

GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.
PRTG Portage Biotech Inc. - Seeking Alpha
Portage Biotech Regains Nasdaq Compliance
Portage Biotech Inc. (PRTG) Cash Flow - Yahoo Finance
See More Headlines

PRTG Stock Analysis - Frequently Asked Questions

Portage Biotech's stock was trading at $5.17 at the start of the year. Since then, PRTG shares have increased by 35.8% and is now trading at $7.02.

Portage Biotech Inc. (NASDAQ:PRTG) issued its quarterly earnings data on Tuesday, November, 26th. The company reported ($1.26) earnings per share for the quarter.

Shares of Portage Biotech reverse split before market open on Thursday, August 15th 2024.The 1-20 reverse split was announced on Tuesday, August 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, August 14th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of PRTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Portage Biotech investors own include Meta Platforms (META), Alimera Sciences (ALIM), Angion Biomedica (ANGN), AirMedia Group (ANTE), Broadcom (AVGO), Barnwell Industries (BRN) and Crescent Biopharma (CBIO).

Company Calendar

Last Earnings
11/26/2024
Today
8/05/2025
Next Earnings (Estimated)
8/26/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PRTG
CIK
1095435
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.02
Quick Ratio
2.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.79) per share
Price / Book
-8.89

Miscellaneous

Outstanding Shares
1,050,000
Free Float
N/A
Market Cap
$7.37 million
Optionable
Optionable
Beta
0.24
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:PRTG) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners